Repaglinide: a new short-acting insulinotropic agent for the treatment of Type 2 diabetes
Author:
Publisher
Wiley
Subject
Clinical Biochemistry,Biochemistry,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2362.1999.00005.x/fullpdf
Reference39 articles.
1. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
2. Pathogenesis of non-insulin-dependent diabetes mellitus
3. Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance
4. A glimpse of the ‘natural history’ of established Type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis
5. Insulin Secretion and Sensitivity in Newly Diagnosed NIDDM Caucasians in the UK
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacotherapy of type 2 diabetes: An update and future directions;Metabolism;2022-12
2. LC-MS/MS Characterization of Forced Degradation Products of Repaglinide Quality by Design Approach for Stability-Indicating LC Method Development and Validation for Degradation Products;Analytical Chemistry Letters;2020-11-01
3. Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide;Drug Testing and Analysis;2017-06-20
4. Glucose-lowering drugs;Diabetes in Old Age;2017-03-07
5. Hyperglycemic and Hypoglycemic Drugs;Synthesis of Best-Seller Drugs;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3